JM Christenson
Abstract
Sotalol is a class III agent with potassium-channel and beta-blocker properties and a 2% to 8% risk of proarrhythmia, including torsades de pointes. Some advocate hospital admission to monitor QT interval prolongation and arrhythmias. This study reviewed outcomes for 120 patients hospitalized for initiation of sotalol …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Sotalol is a class III agent with potassium-channel and beta-blocker properties and a 2% to 8% risk of proarrhythmia, including torsades de pointes. Some advocate hospital admission to monitor QT interval prolongation and arrhythmias. This study reviewed outcomes for 120 patients hospitalized for initiation of sotalol …
Key concepts: Sotalol, Proarrhythmia, Torsades de pointes, Medicine, QT interval, Cardiology, Internal medicine, Anesthesia